EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Astragaloside IV attenuates high-glucose-Induced peritoneal fibrosis via modulation of the ENKUR/PI3K/Akt signalling pathway

Tianxin Jiang, Lijie Zhang, Jiahan Liu, Xinxin Xu, Yuanyuan Shi, Zhanzheng Zhao, Jing Xiao iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0348762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Tianxin Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Saponins, Triterpenes, Peritoneal Fibrosis, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Henan Provincial Key Scientific Research Project Plan for Higher Education Institutions, Shandong Provincial Education Science Plan, the Henan Provincial Medical Science and Technology Research Joint Venture Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to explore the mechanisms by which Astragaloside IV (AS-IV), a major bioactive component of Astragalus membranaceus , mitigates high-glucose-induced peritoneal fibrosis (PF) in peritoneal dialysis (PD). Using both in vivo (uremic rat model) and in vitro (human peritoneal mesothelial cells) approaches, we observed that AS-IV treatment was associated with a significant attenuation of PF. This effect was mediated through the inhibition of epithelial-mesenchymal transition (EMT) and fibrosis. In vivo, AS-IV reduced extracellular matrix deposition and collagen accumulation, downregulated EMT and fibrosis markers (α-SMA, collagen IV), and restored E-cadherin levels. Notably, these changes correlated with the downregulation of ENKUR, pPI3K, and pAkt. The in vitro results corroborated these findings, showing that AS-IV suppressed EMT without cytotoxic effects. Our data indicate that AS-IV may exert antifibrotic effects via modulation of the ENKUR/PI3K/Akt signaling pathway, suggesting a potential target for the prevention of PF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SaponinsTriterpenesPeritoneal FibrosisSignal TransductionProto-Oncogene Proteins c-aktGlucosePhosphatidylinositol 3-KinasesAnimalsHumansEpithelial-Mesenchymal TransitionRatsMaleRats, Sprague-Dawley

Substanzen

Saponinsastragaloside ATriterpenesProto-Oncogene Proteins c-aktGlucosePhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Jing Xiao

Förderung

  • the Henan Provincial Key Scientific Research Project Plan for Higher Education Institutions
  • Shandong Provincial Education Science Plan
  • the Henan Provincial Medical Science and Technology Research Joint Venture Project
  • the National Natural Science Foundation of China
  • the Natural Science Foundation of Henan Province

Zitieren

APA

Jiang, T., Zhang, L., Liu, J., Xu, X., Shi, Y., Zhao, Z., & Xiao, J. (2026). Astragaloside IV attenuates high-glucose-Induced peritoneal fibrosis via modulation of the ENKUR/PI3K/Akt signalling pathway. PLOS One. https://doi.org/10.1371/journal.pone.0348762

Vancouver

Jiang T, Zhang L, Liu J, Xu X, Shi Y, Zhao Z, et al. Astragaloside IV attenuates high-glucose-Induced peritoneal fibrosis via modulation of the ENKUR/PI3K/Akt signalling pathway. PLOS One. 2026. doi:10.1371/journal.pone.0348762

BibTeX
@article{Jiang2026,
  author = {Jiang, Tianxin and Zhang, Lijie and Liu, Jiahan and Xu, Xinxin and Shi, Yuanyuan and Zhao, Zhanzheng and Xiao, Jing},
  title = {Astragaloside IV attenuates high-glucose-Induced peritoneal fibrosis via modulation of the ENKUR/PI3K/Akt signalling pathway},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0348762}
}
Kostenlos starten →